After Hours
$
1.12
Change
-0.06 -5.08%
Volume
Volume 1,226
Aug 9, 2022, 5:08 p.m.
Quotes are delayed by 20 min
Today's close
$ 1.11
$ 1.18
Change
+0.07 +6.31%
Day low
Day high
$1.11
$1.21

52 week low
52 week high
$0.70
$2.00

Market cap
$52.24M
Average volume
160,428
P/E ratio
N/A
Rev. per Employee
$209,296
EPS
-0.54
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on PLX
-
Mellanox: Maxim Ups to Buy; Ethernet Challenge in Disarray
- Barrons Blogs
-
In focus: Awaiting the next move
- Lawrence G. McMillan
-
Using Plants to Make Cheaper Biotech Drugs
- MarketWatch
-
- Barron's Online
-
Wells Fargo cuts Protalix to market perform
- Greg Morcroft
-
Friday’s biggest gaining and declining stocks
- MarketWatch
-
Wednesday’s biggest gaining and declining stocks
- MarketWatch
-
Protalix, Formfactor, Opentable see options volume surge
- blogs.marketwatch.com
-
Canaccord cuts Protalix to hold from buy
- Greg Morcroft
-
Genworth rises, Chesapeake falls after hours
- Myra P. Saefong
-
American Capital options volume surges
- blogs.marketwatch.com
-
Protalix prices shares at 14% discount
- MarketWatch.com
-
Tuesday’s biggest gaining & declining stocks
- Kate Gibson
-
Protalix shares riae 4.6% in preopen trade
- Greg Morcroft
-
FDA accepts Protalix resubmission for Gaucher drug
- MarketWatch.com
-
Israel stocks lower; Ness agrees to takeover
- Robert Daniel
-
Israel stocks fall after central bank’s rate hike
- Robert Daniel
-
Israel stocks edge higher, lifted by energy sector
- Robert Daniel
-
Israel stocks advance, led by finance, property
- Robert Daniel
-
Israel up as Strauss, Migdal, Gazit-Globe report
- Robert Daniel
- Loading more headlines...
Analyst Ratings
-
7 Biggest Price Target Changes For Monday
- Benzinga.com
-
- Benzinga.com
Other News on PLX
-
- Seeking Alpha
-
Protalix BioTherapeutics GAAP EPS of -$0.05, revenue of $16.09M
- Seeking Alpha
-
BioMarin: A Good Anchor For Your Biotech Portfolio
- Seeking Alpha
-
Amicus Therapeutics: An Inflection Point In Growth
- Seeking Alpha
-
VTNR, TKAT and ISIG among mid-day movers
- Seeking Alpha
-
IQ, FUTU and PGEN among pre market gainers
- Seeking Alpha
-
10-K: PROTALIX BIOTHERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Protalix: Fabry BRIGHT Trial Data May Not Be So Bright After All
- Seeking Alpha
-
Protalix Biotherapeutics: Is It Worth The Wait?
- Seeking Alpha
-
10-Q: PROTALIX BIOTHERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Protalix BioTherapeutics Q3 2021 Earnings Preview
- Seeking Alpha
-
Lacking BALANCE, Protalix Tumbles
- Seeking Alpha
- Loading more headlines...
Press Releases on PLX
-
Thursday 4/14 Insider Buying Report: PLX, HCP
- MarketNewsVideo.com
-
Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results
- PR Newswire - PRF
-
Protalix BioTherapeutics to Participate in the 18th Annual WORLDSymposium™ 2022
- PR Newswire - PRF
-
Protalix BioTherapeutics Issues 2021 Letter to Stockholders
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com